Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer
NCT01858805 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 123
Last updated 2014-11-18
Summary
Despite the availability of several preoperative diagnostic techniques, accurate pretreatment staging of esophageal cancer (EC) remains challenging. Therefore, The investigators evaluated the prognostic significance of circulating tumor cells (CTCs) in patients with EC.
Conditions
- Resectable Esophageal Cancer
Interventions
- PROCEDURE
-
esophagectomy
Sponsors & Collaborators
-
Universitätsklinikum Hamburg-Eppendorf
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2014-04-30
- Completion
- 2014-04-30
Countries
- Germany
Study Locations
More Related Trials
-
Genetic and Environmental Risk Factors Related to Esophageal Cancer
NCT01035398 ·Status: ACTIVE_NOT_RECRUITING
-
Organoid Based Response Prediction in Esophageal Cancer
NCT03283527 ·Status: UNKNOWN
-
Esophageal Cancer Risk Registry
NCT00260585 ·Status: RECRUITING
-
Treatment Outcomes of Esophageal Cancer
NCT05177393 ·Status: RECRUITING
-
Wnt, Notch and Hedgehog Activity in Chemo-Naive Tumors Collected During Staging of Esophageal Cancer Patients
NCT02221245 ·Status: TERMINATED
-
Liquid Biopsies in Esophageal Cancer
NCT05704530 ·Status: RECRUITING ·Phase: NA
-
Cologne Esophageal Response Prediction Study (CERP-Study)
NCT00953511 ·Status: COMPLETED ·Phase: NA
-
Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer
NCT01558648 ·Status: COMPLETED
-
Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer
NCT02843581 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
NCT06889402 ·Status: NOT_YET_RECRUITING
-
Discovering Patterns in Experiences of Patients in Esophageal Cancer Clinical Research
NCT05831150 ·Status: NOT_YET_RECRUITING
-
Pilot Sudy: Resectable Esophageal Adenocarcinoma and the Relevance of CTC
NCT02610764 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus
NCT00208936 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresectable ESO
NCT04137679 ·Status: UNKNOWN ·Phase: PHASE2
-
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
NCT02075905 ·Status: COMPLETED
-
Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer
NCT00628368 ·Status: COMPLETED ·Phase: NA
-
Frailty In Thoracic Surgery for Esophageal Cancer
NCT04145726 ·Status: UNKNOWN
-
Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
NCT05894369 ·Status: RECRUITING
-
Staging and Outcome Depending on Surgical Treatment in Adenocarcinomas of the Oesophagogastric Junction
NCT01766986 ·Status: COMPLETED
-
An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal Cancer
NCT03415815 ·Status: UNKNOWN
-
Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
NCT02123381 ·Status: UNKNOWN ·Phase: PHASE2
-
Distribution of Lymph Node Metastases in Esophageal Carcinoma
NCT03222895 ·Status: RECRUITING
-
Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer
NCT03120572 ·Status: COMPLETED
-
Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer
NCT04437212 ·Status: UNKNOWN ·Phase: PHASE2
-
Positron Emission Tomography in Determining Stage of Esophageal Cancer
NCT00004867 ·Status: COMPLETED ·Phase: NA